Affitech renews exclusive worldwide phage display license from DKFZ
"Breitling" patents hold key position in human antibody discovery field
11-Apr-2006 -
Affitech AS, announced that they have renewed an exclusive worldwide licensing agreement with DKFZ (German Cancer Research Center) of Heidelberg, Germany for the antibody library display patents, otherwise known as "Breitling" IP family. These patents cover the use of full-length pIII phage ...
antibodies
antibody fragments
clinical trials
+4